ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
21 Jul 2016 Press Release: ESMO 2018 Annual Congress to be Held in Munich
14 Jul 2016 World GI 2016 Press Release: The Debate on the Phase 3 Trial of MABp1 Presented at the 18th ESMO World Congress on Gastrointestinal Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
07 Jul 2016 Press Release: Results of First Study Assessing Clinical Impact of ESMO-MCBS
06 Jul 2016 Press Release: ESMO Releases New Consensus Guidelines on the Management of Metastatic Colorectal Cancer Gastrointestinal cancers
05 Jul 2016 Press Release: First Oncology Society Partnership for New ESMO Open Access Journal
02 Jul 2016 World GI 2016 Press Release: Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly Over Placebo Gastrointestinal cancers - Cancer Immunology and Immunotherapy
30 Jun 2016 World GI 2016 Press Release: Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
30 Jun 2016 World GI 2016 Press Release: Chemoradiotherapy After Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Jun 2016 World GI 2016 Press Release: Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition Gastrointestinal cancers - Cancer Immunology and Immunotherapy
27 Jun 2016 Press Release: EMA ESMO Workshop - Optimising the use of single arm trials in cancer drug development Anticancer agents & Biologic therapy
27 Jun 2016 ESMO Press Release: ESMO Launches First Leaders Generation Programme to Develop Oncology's Leaders of the Future
13 Jun 2016 ESMO 2016 Media Alert: From Disease Treatment to Patient Care
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours
14 Apr 2016 Press Statement: ESMO Welcomes Final Version of European Data Protection Regulation Bioethics, legal and economic issues